SCHEMBL6030434

SCHEMBL6030434

O=C1CC=C(Cl)C2=C1c1ccccc1NC=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291187 0.72 NPC1 (0.33) —
SCHEMBL16047148 0.65 IDO1 (0.41) —
SCHEMBL29727870 0.65 IDO1 (0.41) —
SCHEMBL28765704 0.61 MAOB (0.45) —
SCHEMBL168935 0.59 PDGFRA (0.52) —
SCHEMBL22134876 0.59 — —
SCHEMBL10900576 0.59 MAOA (0.36) —
SCHEMBL14042850 0.58 MAOA (0.31) —
SCHEMBL29353131 0.58 MAPT (0.41) —
SCHEMBL156862 0.58 MAPT (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1696931-A2 AMINO SUBSTITUTED DIARYL [A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS Acadia Pharmaceuticals Inc. (US) 2006-09-06 — — EP disclosed
WO-2005063254-A2 AMINO SUBSTITUTED DIARYL[A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS ACADIA PHARMACEUTICALS INC. (US) 2005-07-14 — — WO disclosed
Send feedback